Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details. This indicates access restrictions or a server issue affecting the display of the study record.
    Difference
    19%
    Check dated 2026-09-21T21:58:07.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was bumped from v3.6.5 to v3.6.6, representing a minor update; no visible changes to the study information or layout are evident.
    Difference
    0.1%
    Check dated 2026-08-31T17:12:42.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, indicating a small platform update. The change represents an underlying system version bump rather than modifications to study text or results.
    Difference
    0.1%
    Check dated 2026-08-10T02:11:04.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The site revision indicator was updated to v3.6.4, replacing the previous v3.6.3, indicating an update to the platform rather than any study content changes.
    Difference
    0.1%
    Check dated 2026-07-26T18:58:27.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page’s IPD Sharing revision indicator was updated from v3.6.2 to v3.6.3, reflecting a small documentation update.
    Difference
    0.1%
    Check dated 2026-07-05T04:38:08.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is now displayed on the page, signaling a software or content update. The study details and available information remain the same.
    Difference
    0.1%
    Check dated 2026-06-27T23:19:51.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.